BioCentury
ARTICLE | Company News

Xenova/Cantab merger update

April 6, 2001 7:00 AM UTC

Xenova Group (LSE:XEN; XNVA) said it has received 73% of the existing share capital of Cantab Pharmaceuticals (LSE:CTB; CNTBY), under XEN's previously announced stock acquisition of CTB, and the that ...